Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s13277-014-2856-2.pdf
Reference54 articles.
1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–55.
2. Huo TI et al. The model for end-stage liver disease-based Japan integrated scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer. 2006;107(1):141–8.
3. Olsen SK, Brown RS, Siegel AB. Hepatocellular carcinoma: Review of current treatment with a focus on targeted molecular therapies. Therap Adv Gastroenterol. 2010;3(1):55–66.
4. Chang WT et al. Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: Extending the indication for resection? Surgery. 2012;152(5):809–20.
5. Roayaie S et al. Resection of hepatocellular cancer =2 cm: Results from two Western centers. Hepatology. 2013;57(4):1426–35.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. UCK2 regulated by miR-139-3p regulates the progression of hepatocellular carcinoma cells;Future Oncology;2022-03
2. Biguanides decorated albumin nanoparticles loading nintedanib for synergic enhanced hepatocellular carcinoma therapy;Colloids and Surfaces B: Biointerfaces;2021-11
3. Downregulation of transcription factor TCTP elevates microRNA-200a expression to restrain Myt1L expression, thereby improving neurobehavior and oxidative stress injury in cerebral palsy rats;Cell Cycle;2020-03-15
4. Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy;Frontiers in Pharmacology;2020-03-06
5. Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma;Cancer Management and Research;2019-10
Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3